Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) reflects myocardial fibrosis and has been associated with adverse outcomes in hypertrophic cardiomyopathy (HCM). We sought to measure its incremental prognostic value beyond established clinical and phenotypic variables in a large contemporary HCM...
H. Sheashaa, S. Keen, S. Shah et al.· European Heart Journal· 0 citations
Left ventricular (LV) myocardial extracellular volume (ECV), derived from cardiac magnetic resonance (CMR) T1 mapping, reflects diffuse interstitial fibrosis and has emerged as a quantitative marker of adverse myocardial remodeling in hypertrophic cardiomyopathy (HCM). We aimed to determine the independent prognostic...
S. Shah, S. Keen, H. Sheashaa et al.· European Heart Journal· 0 citations
Current methods to predict risk of adverse events in hypertrophic cardiomyopathy (HCM) are based on retrospective studies from select tertiary centers. The HCM Registry (HCMR) is a prospective registry, funded by the NHLBI, USA to aid in development of clinical and imaging markers that could improve event predict...
M. Desai, P. Kolm, J. Di Marco et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.